What's happening
This bill adds cannabimimetic agents, including synthetic cannabinoids, to New York's Schedule I controlled substances list.
Why it matters
Expands the definition of controlled substances. by explicitly including a broad range of synthetic cannabinoids (cannabimimetic agents), many of which are designed to mimic the effects of THC but may have unpredictable or dangerous health effects.
Targets specific chemical classes and compounds. , meaning not only currently known synthetic cannabinoids (such as JWH-018, CP-47,497, and others) but also future analogs and slight chemical modifications intended to skirt existing regulations will be covered, closing loopholes used by manufacturers.
Aligns state law with evolving drug trends. , addressing the rapid proliferation of synthetic drugs sold under names like “K2” or “Spice” that have been linked to outbreaks of severe health emergencies, especially in youth and vulnerable populations.
Enables law enforcement and health authorities to more effectively regulate, prosecute, and remove these substances from the market. , potentially reducing the incidence of synthetic cannabinoid-related poisonings, overdoses, and public health risks.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Ban Synthetic Weed Chemicals
Plain English, a few words. Used as the page title.
Sponsors
18 Co-sponsors
History
- Referred to codes
- Delivered to senate
- Passed assembly
- Ordered to third reading cal.98
- Returned to assembly
- Died in senate
- Referred to rules
- Delivered to senate
- Passed assembly
- Ordered to third reading rules cal.83
- Rules report cal.83
- Reported
Show 3 earlier actions
- Reported referred to rules
- Reported referred to codes
- Referred to health
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
1384
2017-2018 Regular Sessions
IN ASSEMBLY
January 12, 2017
Introduced by M. of A. ZEBROWSKI, CUSICK, ORTIZ, GALEF, COLTON, JENNE, BRINDISI, JAFFEE, TITUS, GUNTHER, COOK, TITONE, MAGNARELLI, BARRETT, STIRPE, BUCHWALD, LOPEZ, MOSLEY, HUNTER -- Multi-Sponsored by -- M. of A. BARCLAY, CROUCH, DINOWITZ, FINCH, HAWLEY, MAGEE, McKEVITT, MONTES- ANO, PALMESANO, PEOPLES-STOKES, PERRY, RODRIGUEZ, STECK -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to adding cannabimimetic agents to the schedule of controlled substances
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Schedule I of section 3306 of the public health law is amended by adding a new subdivision (g) to read as follows:
(g) (1) Cannabimimetic agents. Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation that is not approved by the federal food and drug administration (FDA) which contains any quantity of cannabimimetic agents, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.
(2) As used in this subdivision, the term "cannabimimetic agents" means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist as demonstrated by binding studies and functional assays within any of the following structural classes:
(i) 2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.
(ii) 3-(1-naphthoyl)indole or 3-(1-naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD04439-01-7
A. 1384 2
(iii) 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent.
(iv) 1-(1-naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.
(v) 3-phenylacetylindole or 3-benzoylindole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent.
(3) Such term includes:
(i) 5-(1,1-dimethylheptyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol (CP-47,497);
(ii) 5-(1,1-dimethyloctyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);
(iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);
(iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);
(v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019);
(vi) 1-{2-(4-morpholinyl)ethyl}-3-(1-naphthoyl)indole (JWH-200);
(vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);
(viii) 1-pentyl-3-{1-(4-methoxynaphthoyl)}indole (JWH-081);
(ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);
(x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);
(xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);
(xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);
(xiii) 1-pentyl-3-{(4-methoxy)-benzoyl}indole (SR-19 and RCS-4);
(xiv) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8); and
(xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).
§ 2. This act shall take effect on the ninetieth day after it shall have become a law.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.